GlassScriptPhysician profile
Suresh P Jain
NPI 1740203686
$5,205.37
in general payments reported to CMS, 2019-2025
24 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,643 · 2020: $158 · 2021: $404 · 2022: $966 · 2023: $550 · 2024: $150 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,034.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,033.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,096.93 | 2019-2025 | Rotapro, General - Therapies, Avvigo Guidance System |
| Medtronic Vascular, INC. | $851.02 | 2019 | |
| Cardiovascular Systems INC. | $825.77 | 2019-2022 | |
| Medtronic, INC. | $618.11 | 2021-2024 | In.Pact Admiral, Abre, Onyx Frontier |
| Abbott Laboratories | $393.81 | 2020-2024 | Esprit |
| Venturemed Group, INC. | $274.44 | 2019 | |
| Inari Medical, INC. | $152.96 | 2021-2022 | |
| Shockwave Medical, INC | $149.06 | 2025 | |
| Cardinal Health 200 LLC | $148.55 | 2019 | |
| Penumbra, INC. | $105.70 | 2025 | Indigo System |
| Abiomed | $95.76 | 2019 | |
| Alexion Pharmaceuticals, INC. | $87.62 | 2022 | |
| Pfizer INC. | $63.74 | 2022-2023 | |
| Teleflex LLC | $55.23 | 2020 | |
| Kestra Medical Technology Services, INC. | $50.23 | 2023 | Assure Wcd |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.70 | 2021 | |
| Novartis Pharmaceuticals Corporation | $35.15 | 2019-2022 | |
| Philips North America LLC | $25.84 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $24.85 | 2023 | Eliquis |
| Saranas, INC. | $21.82 | 2023 | |
| Merck Sharp & Dohme LLC | $21.70 | 2022 | |
| Cook Medical LLC | $21.63 | 2023 | Zenith Spiral-Z |
| Z-Medica, LLC | $19.87 | 2020 | |
| Janssen Pharmaceuticals, INC | $18.88 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Jain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.